Collaborating with government agencies to develop treatment for COVID-19: Cipla

Besides scaling up production of medicines that show potency against the virus -- Lopinavir + Ritonavir, Hydroxychloroquine and Azithromycin, the company is also ramping up manufacturing of drugs for chronic ailments such as asthma, COPD, among others.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kdoXGC
via IFTTT